XML 70 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value of Financial Instruments
12 Months Ended
Dec. 28, 2014
Fair Value of Financial Instruments [Abstract]  
Fair Value of Financial Instruments
(12)            Fair Value of Financial Instruments

The Company measures certain assets at fair value in accordance with current accounting standards. The fair value hierarchy consists of three levels: Level 1 fair values are valuations based on quoted market prices in active markets for identical assets or liabilities that the entity has the ability to access; Level 2 fair values are those valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and Level 3 fair values are valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. There have been no transfers between levels within the fair value hierarchy.

Current accounting standards permit entities to choose to measure many financial instruments and certain other items at fair value and establish presentation and disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar assets and liabilities. The Company has elected the fair value option for certain investments. At December 28, 2014 and December 29, 2013, these investments totaled $23,560 and $28,048, respectively, and are included in prepaid expenses and other current assets in the consolidated balance sheets. The Company recorded net gains of $267, $152 and $2,504 on these investments in other (income) expense, net for the years ended December 28, 2014, December 29, 2013 and December 30, 2012, respectively, relating to the change in fair value of such investments.

At December 28, 2014 and December 29, 2013, the Company had the following assets and liabilities measured at fair value in its consolidated balance sheets:

    
Fair Value Measurements Using
 
  
Fair
Value
  
Quoted Prices in Active Markets for Identical Assets
(Level 1)
  
Significant Other Observable Inputs
(Level 2)
  
Significant Unobservable Inputs
(Level 3)
 
         
December 28, 2014
        
Assets:
        
Available-for-sale securities
 
$
28,042
   
4,482
   
17,773
   
5,787
 
Derivatives
  
69,148
   
-
   
69,148
   
-
 
Total assets
 
$
97,190
   
4,482
   
86,921
   
5,787
 
                 
Liabilities:
                
Derivatives
 
$
2,591
   
-
   
2,591
   
-
 
Option agreement
  
25,340
   
-
   
-
   
25,340
 
Total Liabilities
 
$
27,931
   
-
   
2,591
   
25,340
 
                 
December 29, 2013
                
Assets:
                
Available-for-sale securities
 
$
28,048
   
-
   
22,564
   
5,484
 
Derivatives
  
4,627
   
-
   
4,627
   
0
 
Total assets
 
$
32,675
   
-
   
27,191
   
5,484
 
                 
Liabilities:
                
Derivatives
 
$
12,330
   
-
   
12,330
   
-
 
Total Liabilities
 
$
12,330
   
-
   
12,330
   
-
 

Available-for-sale securities include equity securities of one company quoted on an active public market as well as certain investments valued at net asset values quoted on private markets that are not active. These net asset values are predominantly based on underlying investments which are traded on an active market; investments are redeemable within 45 days. At December 29, 2013 the Company also held an available-for-sale investment in Brazil similar to a repurchase agreement; this investment was valued at the principal plus any interest accrued on the instrument. Lastly, the Company holds an available-for-sale investment which invests in hedge funds which contain financial instruments that are valued using certain estimates which are considered unobservable in that they reflect the investment manager's own assumptions about the inputs that market participants would use in pricing the asset or liability. The Company believes that these estimates are the best information available for use in the fair value of this investment. The Company's derivatives consist primarily of foreign currency forward contracts. At December 29, 2013, the Company also had forward-starting interest rate swap contracts related to the anticipated issuance of the Notes Due 2021 and 2044. The Company used current forward rates of the respective foreign currencies and U.S. treasury interest rates to measure the fair value of these contracts. The option agreement included in other liabilities at December 28, 2014 is valued using an option pricing model based on the fair value of the related investment. Inputs used in the option pricing model include volatility and fair value of the underlying company which are considered unobservable inputs as they reflect the Company's own assumptions about the inputs that market participants would use in pricing the asset or liability. The Company believed that this is the best information available for use in the fair value measurement. There were no changes in these valuation techniques during 2014.
The following is a reconciliation of the beginning and ending balances of the fair value measurements of the Company's financial instruments which use significant unobservable inputs (Level 3):
  
2014
  
2013
 
Balance at beginning of year
 
$
5,484
   
7,618
 
Issuance of option agreement
  
(25,590
)
  
-
 
Sales
  
-
   
(990
)
Net gain (loss) from change in fair value
  
553
   
(1,144
)
Balance at end of year
 
$
(19,553
)
  
5,484